Live Breaking News & Updates on Sankyo Group|Page 7

Stay updated with breaking news from Sankyo group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Daiichi Sankyo: New data further strengthens important role of LIXIANA (edoxaban) in managing complex patient populations with atrial fibrillation (AF)

Data from the ETNA-AF-Europe Registry provide insights on edoxaban in routine clinical practice in patient subpopulations including those who are frail, with heart failure or insulin-dependent diabetes1 ....

Wolfgang Schiessl , Stefan Seyfried , Daiichi Sankyo , Daiichi Sankyo Europe , Daiichi Sankyo Europe Gmb , University Of Pisa , European Society Of Cardiology Congress , Pisa University Hospital , Sustainable Development Of Society , Innovative Global Healthcare Company , European Society Of Cardiology , European Heart Rhythm Association Practical , University Cardiology Division , Edoxaban Clinical Research Programme , Europe Registry , European Society , Sankyo Europe , Cardiology Congress , Raffaele De Caterina , Pisa University , Vice President , Medical Affairs , Specialty Medicines , Global Healthcare Company Contributing , Sustainable Development , Exodaban Treatment ,

Daiichi Sankyo: Quizartinib Marketing Authorization Application Validated by EMA for Treatment of Adult Patients with Newly Diagnosed FLT3-ITD Positive Acute Myeloid Leukemia

Submission based on QuANTUM-First results showing quizartinib plus chemotherapy significantly improved overall survival compared to chemotherapy alone Daiichi Sankyo (TSE: 4568) today announced ....

United States , Zuccae Ann , Masashi Kawase , Simone Jendsch Dowe , Ken Takeshita , Daiichi Sankyo , Daiichi Sankyo Europe Gmb , Jennifer Brennan , Daiichi Sankyo Inc , University Of Texas Md Anderson Cancer Center , Drug Administration , European Hematology Association , Sustainable Development Of Society , Daiichi Sankyo Co Ltd , Innovative Global Healthcare Company , European Medicines Agency , Committee For Medicinal Products Human Use , American Cancer Society , Global Head , Medicinal Products , Human Use , North America , Acute Myeloid Leukemia , Cancer Center , Orphan Drug Designation , Fast Track Designation ,

Daiichi Sankyo: Datopotamab Deruxtecan-Based Combinations Show Promising Clinical Activity in Patients with Advanced Non-Small Cell Lung Cancer

Late-breaking oral presentation at WCLC features first results from TROPION-Lung02 trial of Daiichi Sankyo and AstraZeneca's TROP2 directed antibody drug conjugate Initial results from the TROPION-Lung02 ....

United States , Japan General , Masashi Kawase , Ann Onc , Daiichi Sankyo , Rose Talarico , Cristian Massacesi , Daiichi Sankyo Company , National Cancer Institute , Merck Co Inc , International Agency For Research On Cancer , Virtual Congress , American Cancer Society , Centers For Disease , Daiichi Sankyo Inc , Oncology Development , Johns Hopkins Sidney Kimmel Cancer Center , World Health Organization , Sapporo Medical University , Sustainable Development Of Society , Daiichi Sankyo Co Ltd , Innovative Global Healthcare Company , Lung Cancer , International Association , Benjamin Philip Levy , Clinical Director ,

Daiichi Sankyo: ENHERTU Approved in the EU for Patients with HER2 Positive Metastatic Breast Cancer Treated with One or More Prior Anti-HER2-Based Regimens

Approval broadens indication for Daiichi Sankyo and AstraZeneca's ENHERTU across Europe to earlier use in HER2 positive metastatic breast cancer Based on groundbreaking DESTINY-Breast03 results ....

United States , Masashi Kawase , Daiichi Sankyo , Daiichi Sankyo Europe Gmb , Simone Jendsch Dow , Daiichi Sankyo Inc , Daiichi Sankyo Company , European Commission , Clinical Development Program , Sustainable Development Of Society , Daiichi Sankyo Co Ltd , Committee For Medicinal Products Human , European Union , Innovative Global Healthcare Company , Medicinal Products , Human Use , New England Journal , North America , Breakthrough Therapy Designation , Sankyo Company , Global Healthcare Company Contributing , Sustainable Development , Pathol Transl , Sankyo Europe Gmbh ,

Reviving the Pharmaceutical Industry: 'Late Starts to Drug Discovery'

In Japan, Daiichi Sankyo began developing an mRA vaccine about the same time as Pfizer and Moderna, but the know-how to connect this society was lacking. ....

United States , South Korea , Ken Ishii , Daiichi Sankyo Tooru Tanzawa , Daiichi Sankyo , Short Sighted Ministry , Institute Of Medical Science , University Of Tokyo , University Of Pennsylvania , Us Department Of Defense , Japan Agency For Medical Research , Katalin Kariko , Japan Prize , United State , Ethical Sense , Japan Agency , Medical Research , Re Emerging Infectious Disease Management , Japan Missed , Medical Science , Middle East Respiratory Syndrome , Developing Human Capital , Wuhan Province , Warp Speed , Tooru Tanzawa , Vaccine Defeat ,